Evidence map›Paper›PMID 37592969›Full record

ReviewAntimicrobial stewardship & healthcare epidemiology : ASHE2023

Considerations for de-escalating universal masking in healthcare centers.

Caroline Landelle, Gabriel Birgand, James R Price, Nico T Mutters, Daniel J Morgan, Jean-Christophe Lucet, Solen Kerneis, Walter Zingg

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Erratum: Considerations for de-escalating universal masking in healthcare centers - CORRIGENDUM.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 5 countries.

Caroline LandelleUniversity of Grenoble Alpes, CNRS, UMR 5525, Grenoble INP, CHU Grenoble Alpes, Infection Prevention and Control Unit, 38000 Grenoble, France.
Gabriel BirgandNational Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-5371-2808
James R PriceBrighton and Sussex Medical School, Brighton, UK.ORCID https://orcid.org/0000-0003-2541-8545
Nico T MuttersInstitute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany.
Daniel J MorganUniversity of Maryland School of Medicine, Baltimore, MD, USA.
Jean-Christophe LucetInfection Control Unit, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France.
Solen KerneisInfection Control Unit, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France.
Walter ZinggDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, Zurich, Switzerland.
Université Claude Bernard Lyon 1 · FRBrighton and Sussex Medical School · GBCentre Hospitalier Universitaire de Nantes · FRHôpital Beau-Séjour · CHInstitut polytechnique de Grenoble · FRUniversity Hospital Bonn · DEUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three years after the beginning of the COVID-19 pandemic, better knowledge on the transmission of respiratory viral infections (RVI) including the contribution of asymptomatic infections encouraged most healthcare centers to implement universal masking. The evolution of the SARS-CoV-2 epidemiology and improved immunization of the population call for the infection and prevention control community to revisit the masking strategy in healthcare. In this narrative review, we consider factors for de-escalating universal masking in healthcare centers, addressing compliance with the mask policy, local epidemiology, the level of protection provided by medical face masks, the consequences of absenteeism and presenteeism, as well as logistics, costs, and ecological impact. Most current national and international guidelines for mask use are based on the level of community transmission of SARS-CoV-2. Actions are now required to refine future recommendations, such as establishing a list of the most relevant RVI to consider, implement reliable local RVI surveillance, and define thresholds for activating masking strategies. Considering the epidemiological context (measured via sentinel networks or wastewater analysis), and, if not available, considering a time period (winter season) may guide to three gradual levels of masking: (i) standard and transmission-based precautions and respiratory etiquette, (ii) systematic face mask wearing when in direct contact with patients, and (iii) universal masking. Cost-effectiveness analysis of the different strategies is warranted in the coming years. Masking is just one element to be considered along with other preventive measures such as staff and patient immunization, and efficient ventilation.

Indexed as

COVID-19healthcare settinginfection controlmedical face maskrespiratory viral infectionsuniversal masking

Identifiers

PMID37592969
PMCPMC10428150
OpenAlexW4385281561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.